Mutations of Ki‐ras oncogene codon 12 in betel quid chewing‐related human oral squamous cell carcinoma in Taiwan

Journal of Oral Pathology & Medicine

Volumn 23, Issue 2, 1994, Pages 70-74

  Kuo, M Y P ^a   Jeng, J H ^a   Chiang, C P ^a   Hahn, L J ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Betel quid chewing; oral cancer; ras oncogenes

Indexed keywords

EID: 0028370026     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1994.tb00259.x     Document Type: Article

References (38)

1. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: A preliminary report
2. Cancer epidemiology: the Indian scene
3. Slaked lime and betel nut cancer in Papua New Guinea
4. Correlation of mutagenicity and tumorigenicity of betel quid and its ingredients
5. Mutagenicity of betel quid and its ingredients using mammalian test systems
6. Cytotoxic and genotoxic effects of areca nut‐related compounds in cultured human buccal epithelial cells
7. Ras genes
8. Ras oncogenes in human cancer: a review
9. Low incidence of ras oncogene activation in human squamous cell carcinomas
10. Analysis of the c‐Ha‐ras‐l gene for deletion, mutation, amplification and expression in lymph node metastasis of human head and neck carcinomas
11. Ras mutations in United Kingdom examples of oral malignancies are infrequent
12. Point mutations in the Haras oncogene are detactable in formalin‐fixed tissues of oral squamous cell carcinomas, but are infrequent in British cases
13. Ras gene point mutation is a rare event in premalignant tissues and malignant cells and tissues from oral mucosal lesions
14. High frequency mutations in codons 12 and 61 of H‐ras oncogene in chewing tobacco‐related human oral carcinoma in India
15. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors
16. Multiple K‐ras codon 12 mutations in chloangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique
17. DNA Sequence Analysis with a modified bacteriophage T7 DNA Polymerase
18. 6‐methylguanine
19. 6‐methyl‐guanine built into a unique site in a viral genome
20. Mutational activation of the K‐ras oncogenes: a possible pathogenetic factor in adenocarcinoma of the lung
21. Analysis of ras gene mutation in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes
22. Primer‐directed enzymatic amplification of DNA with a thermostable DNA polymerase
23. Fidelity of DNA polymerases in DNA amplifications
24. HIV‐1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions
25. Thermostable DNA polymerases
26. Tumorigenic tranformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus
27. Expression of ras oncogene p2l in prostate cancer
28. Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer
29. ras in fresh primary and metastatic human colorectal tumors
30. ras in normal and malignant human tissues: lack of association with proliferation and malignancy
31. The relation of ras oncogene product p2l expression to clinicopathological status criteria and clinical outcome in squamous cell head and neck cancer
32. The immunohistochemical detection of ras p21 and its correlation with differentiation in oral cancers
33. Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinomas
34. Oncogenes and tumour‐suppressor genes in squamous cell carcinoma of the head and neck
35. Prevalence of ras gene mutations in human colorectal cancers
36. Detection of high incidence of K‐ras oncogenes during human colon tumorigenesis
37. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis
38. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of ras point mutations with differentiation phenotype